Sign in

CIK 0001497253

  • Non-accelerated filer
  • Smaller reporting company

VivoSim Labs, INC.

Sign in to watch
Ticker
VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
271488943
Phone
+1 858-224-1000
Business address
11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
Former names
ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
Open-market buys, last 90 days
$2,804
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lialin Tony Serge +$3K Chief Commercial Officer 1 filing

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-16 Gallant Paul General Manager Shares withheld for taxes −7,820 $1.09 $8K 180,579
2018-02-16 Bush Jennifer General Counsel & Secretary Shares withheld for taxes −10,365 $1.09 $11K 244,815
2017-11-24 Murphy Keith Former affiliate last filing Purchase +200,500 $1.49 $299K 6,373,673
2017-11-22 Murphy Keith Former affiliate last filing Purchase +135,000 $1.50 $202K 6,173,173
2017-11-16 Presnell Sharon Collins Chief Scientific Officer Shares withheld for taxes −5,860 $1.47 $9K 287,213
2017-11-16 KUSSMAN CRAIG Chief Financial Officer Shares withheld for taxes −11,890 $1.47 $17K 313,748
2017-11-16 Gallant Paul General Manager Shares withheld for taxes −7,015 $1.47 $10K 188,399
2017-11-16 David Eric CSO & EVP Pre-Clinical Dev Shares withheld for taxes −5,625 $1.47 $8K 876,609
2017-11-16 Bush Jennifer General Counsel & Secretary Shares withheld for taxes −8,900 $1.47 $13K 255,180
2017-08-24 Maroun Richard E Director Grant or award · Stock Option (Right to Buy) +42,500 42,500
2017-08-24 Malloy Kirk Director Grant or award · Stock Option (Right to Buy) +42,500 42,500
2017-08-24 KESSEL MARK Director Grant or award · Stock Option (Right to Buy) +42,500 42,500
2017-08-24 HOWSON TAMAR D Director Grant or award · Stock Option (Right to Buy) +42,500 42,500
2017-08-24 GLOVER JAMES T Director Grant or award · Stock Option (Right to Buy) +42,500 42,500
2017-08-24 Baltera Robert Jr. Director Grant or award · Stock Option (Right to Buy) +42,500 42,500
2017-08-16 Presnell Sharon Collins Chief Scientific Officer Shares withheld for taxes −6,115 $2.06 $13K 293,073
2017-08-16 KUSSMAN CRAIG Chief Financial Officer Shares withheld for taxes −26,362 $2.06 $54K 325,638
2017-08-16 Gallant Paul General Manager Shares withheld for taxes −7,324 $2.06 $15K 195,414
2017-08-16 David Eric CSO & EVP Pre-Clinical Dev Shares withheld for taxes −8,469 $2.06 $17K 882,234
2017-08-16 Bush Jennifer General Counsel & Secretary Shares withheld for taxes −5,871 $2.06 $12K 264,080

Page 8 of 13 · 259 trades